文献速递青光眼小儿眼科与斜弱视

Aurolab房水引流植入物联合或不联合巩膜补片治疗难治性成人及儿童青光眼的比较研究

Aurolab Aqueous Drainage Implant With and Without Scleral Patch Graft in Refractory Adult and Pediatric Glaucomas: A Comparative Study.
PubMed 文献 · Am J Ophthalmol · 2020-03-26

本回顾性比较干预病例系列纳入215只成人眼和111只儿童眼,比较Aurolab房水引流植入物(AADI)联合或不联合巩膜补片植入的2年结局。结果显示两组在眼压、视力、抗青光眼药物数量及并发症方面多数时间点无差异,无补片组无管暴露发生,2年累积成功率在成人和儿童中均相似。结论认为不联合巩膜补片的AADI植入在难治性成人及儿童青光眼中与联合补片同样安全有效。

要点

  • 无补片组成人眼术后1个月眼压较高,但儿童眼无此差异。
  • 两组在其他时间点的眼压、视力、用药数及并发症均无差异。
  • 无补片组无管暴露发生,2年累积成功率两组相似。

核心结论

  • 不联合巩膜补片的AADI植入在难治性成人及儿童青光眼中与联合补片同样安全有效。

研究设计与样本

  • 回顾性比较干预病例系列,纳入AADI植入且随访至少2年的215只成人眼和111只儿童眼。
  • 2016年1月前手术者使用巩膜补片覆盖管远端,此后手术者采用针制巩膜隧道而不使用补片。

主要发现

  • 成人无补片组术后1个月眼压高于有补片组(27.5 ± 14.1 vs 22.3 ± 11.1,P = .01),儿童组无差异(14.3 ± 5.8 vs 17.8 ± 11.0,P = .39)。
  • 两组在其他时间点的眼压、视力、抗青光眼药物数量及并发症均无差异。
  • 无补片组无管暴露发生。
  • 2年累积成功率在成人中分别为66.2%与63.9%(P = .85),在儿童中分别为77.2%与71.9%(P = .83)。

关键数值与推荐

  • AADI累积失败定义为术后3个月后连续2次随访眼压>18 mm Hg或较基线下降不足30%。

临床怎么用

  • 在难治性成人及儿童青光眼中,AADI植入可不联合巩膜补片,其安全性和有效性与联合补片相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the 2-year outcomes of eyes that received the Aurolab aqueous drainage implant (AADI) with and without a scleral patch graft. DESIGN: Retrospective comparative interventional case series. METHODS: Eyes with AADI and a minimum of a 2-year follow-up were included. Eyes that underwent implantation before January 2016 had surgery with a scleral patch graft covering the distal end of the tube, whereas those that were implanted after this period underwent surgery using a needle-generated scleral tunnel without the patch graft. The cumulative failure of the AADI was defined as intraocular pressure (IOP) >18 mm Hg or not reduced by 30% below baseline on 2 consecutive follow-up visits after 3 months. RESULTS: We included 215 adult eyes (n = 147 with patch graft, n = 68 without patch graft) and 111 pediatric eyes (n = 73 with patch graft, n = 38 without a patch graft). The mean IOP in eyes without the patch graft was higher at 1 month in adult eyes (before, 27.5 ± 14.1 vs after, 22.3 ± 11.1; P = .01) but not in pediatric eyes (14.3 ± before, 5.8 vs after, 17.8 ± 11.0; P = .39); there were no differences in IOP, vision, number of antiglaucoma medications, and complications between groups at all other time points. None of the eyes without the patch graft experienced tube exposure. Cumulative success rates at 2 years in adults (66.2% vs 63.9%, respectively; P = .85) were similar to those in children (77.2% vs 71.9%, respectively; P = .83) with both techniques. CONCLUSIONS: AADI placed without a scleral patch graft is as safe and effective as AADI placed with a patch graft in pediatric and adult refractory glaucomas.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Puthuran GV, Palmberg P, Wijesinghe HK, et al. Aurolab Aqueous Drainage Implant With and Without Scleral Patch Graft in Refractory Adult and Pediatric Glaucomas: A Comparative Study. Am J Ophthalmol. 2020. PMID: 32222366. doi:10.1016/j.ajo.2020.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。